Mereo BioPharma Group plc Cash Flow Statement

Cash Flow Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -52.98M10.44M-42.78M7.96M-210.12M17.15M-42.22M-29.47M-43.25M
Depreciation and Depletion 0.05M0.05M0.20M0.20M0.14M
Share-based Compensation 8.81M4.70M2.92M2.09M2.00M4.45M4.77M4.92M7.39M
Deferred Taxes -0.51M2.66M0.59M0.28M
Gains from Sales and Divestitures 0.50M1.34M
Gains from Investment Securities -0.07M0.96M1.12M13.96M-9.29M-1.34M-1.75M
Non-cash Items 10.69M0.01M8.12M15.76M
Cash from Operations -40.24M-41.42M-30.90M-58.65M-36.39M-7.06M-48.82M-21.13M-32.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.71M0.49M0.51M
Depreciation & Amortization (CF) 0.04M0.05M0.05M2.01M2.05M0.87M0.90M0.20M0.14M
Change in Working Capital
Change in Receivables -1.65M-1.08M1.07M-1.20M0.18M-0.79M0.86M
Change in Account Payables -1.04M4.97M2.14M-8.59M-4.56M-1.69M0.62M-1.26M0.15M
Change in Accured Expenses 0.84M-0.71M-1.19M
Change in Taxes 10.50M7.05M8.01M3.62M-2.04M2.35M
Other Working Capital Changes -0.88M-0.58M-2.98M
Investing Activities
Capital Expenditures 0.00M0.02M0.05M0.03M0.02M0.72M0.01M
Sales of Property, Plant and Equipment 0.00M0.00M
Change in Intangibles 0.42M0.70M
Acquisitions 12.86M
Change in Acquisitions & Divestments -3.22M41.96M
Cash from Investing Activities 0.51M-4.82M0.34M55.28M1.92M-0.57M1.99M-0.42M-0.70M
Financing Activities
Other financing activities -4.06M-0.94M0.10M-0.97M0.51M0.85M
Cash from Financing Activities 92.73M43.47M-2.77M-7.29M44.61M104.68M0.20M7.97M46.15M
Additional items
Exchange Rate Effect 3.07M-1.78M-0.05M-0.45M-0.99M-1.57M-12.58M2.82M-0.23M
Change in Cash 53.00M-2.77M-33.34M-10.66M10.13M97.05M-46.63M-10.76M12.38M
Free Cash Flow -40.24M-41.44M-30.95M-58.67M-36.41M-7.78M-48.83M-21.13M-32.83M
Net Cash Flow 53.00M-2.77M-33.34M-10.66M10.13M97.05M-46.63M-13.58M12.61M